Happy 10th bday to @GooglePhotos! It was an early example of AI research becoming reality, using deep neural networks to search in an entirely new way. Now our 1.5B monthly users search their 9T(!) photos videos 370M times every month - incredible progress!
Hi everyone, so I wanted to see how far I could push AI, build a complete SaaS application in just a few hours, something that would have take months and months do previously! Well it’s done ! drivey-space.lovable.app/ Proof of concept @lovable
The MacAdmins Conference team is devastated to hear about the passing of a beloved community member Charles Edge ( @cedge318/ @krypted). Their impact was profound, and their absence will be deeply felt. Our thoughts are with their family and loved ones during this difficult time.
I've been to several very low points mentally over the past 2 years. I'm deeply grateful for the love & support I've received along the way. If you're struggling, I send you my love. We're in this together. ❤
Show us your #Zappi stats
Zappi 1 from Sept 2018
6,678.97 kWh
67% Green (solar)
33% Grid/Battery
278days 20hr 11min of charging
@myenergiuk
We avg 4.3miles per kwh
28,715 miles of Electric driving
19,264 miles on solar power
Medtronic has announced that its long-awaited 780G diabetic therapy system has gained FDA approval which includes support for iPhone and Apple Watch monitoring.
appleinsider.com/articles/23…
Everyone is talking about OpenAI, Microsoft and Stability as a huge AI player.
But there is one company that arguable the best positioned in the space, and they dont even have an LLM offering yet.
Apple has the potential to shift the entire AI landscape, here's how:
NEW: Apple plans an AI-powered Health and Wellness digital coaching service for next year. Plus, the Health app is coming to the iPad this year alongside new features for mood and emotion tracking and vision condition management. bloomberg.com/news/articles/…
In an effort to expand the availability of BAQSIMI, the first and only nasally administered glucagon for people living with type 1 diabetes (T1D), Lilly has entered into an agreement to divest BAQSIMI to Amphastar, a global pharmaceutical company. (1/2)